Quality of Life in Children with Neurofibromatosis Type 1, Based on Their Mothers' Reports

dc.authorid0000-0002-6749-5795
dc.contributor.authorSaltik, Sema
dc.contributor.authorBasgul, Saziye Senem
dc.date.accessioned2025-05-10T19:28:42Z
dc.date.issued2013
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective: The aim of this study was to investigate health-related quality of life (HRQoL) in children with neurofibromatosis type 1 (NF1) and to determine the factors affecting HRQoL in these children, with particular emphasis on NF1-specific findings and complications. Materials and Methods: The patient group included 60 NF1 patients aged 3-18 years that were evaluated at our pediatric neurology outpatient clinic between January 2001 and January 2011. The control group included 96 age-matched patients without chronic disease and whose mothers had similar levels of education as the mothers of those in the patient group. All the mothers completed the Pediatric Quality of Life Inventory PedsQoL-Parent Form and the PedsQoL scores in the 2 groups were statistically compared. In addition, the effects of sociodemographic variables, as well as NF1-specific findings and complications (skin findings, neurofibromas, Lisch nodules, arterial hypertension and/or cardiac pathology, short stature, macrocephaly, orthopedic problems, hyperintense lesions on cranial MRI, epileptic seizures, psychiatric disease, and cognitive involvement) were statistically analyzed. Results: All PedsQoL domain scores were lower in the patient group than in the control group (P = 0.0001). HRQoL decreased, and the number of NF1-specific findings and complications increased as age increased in the patient group (P = 0.013). Short stature, neurofibromas and/or plexiform neurofibromas, bone lesions, and psychiatric problems were factors specifically related to low-level HRQoL in the NF1 patients. Conclusion: NF1 negatively affected HRQoL in the patient group. We think that multidisciplinary evaluation and, in particular, Psychiatric management of NF1 patients are necessary to improve patient HRQoL.
dc.identifier.endpage34
dc.identifier.issn1300-2163
dc.identifier.issue1
dc.identifier.pmid23446537
dc.identifier.scopus2-s2.0-84880588189
dc.identifier.scopusqualityQ3
dc.identifier.startpage25
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7445
dc.identifier.volume24
dc.identifier.wosWOS:000333547800005
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isotr
dc.publisherTurkiye Sinir Ve Ruh Sagligi Dernegi
dc.relation.ispartofTurk Psikiyatri Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectNeurofibromatosis type 1
dc.subjectquality of life
dc.subjectchildren
dc.titleQuality of Life in Children with Neurofibromatosis Type 1, Based on Their Mothers' Reports
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
7445
Boyut:
77.88 KB
Biçim:
Adobe Portable Document Format